Recently, I joined Adam Marr and Katie Walker on the Revitalist Clinic Podcast to discuss some of the most exciting developments in pain management. Our conversation explored the roles of ketamine and alternative, holistic therapies in transforming the landscape of treatment for chronic pain and PTSD.

1 in 5 Americans experience chronic pain, which now exceeds the prevalence of diabetes and depression. Dr Weiner explores how a bio-psycho-social approach offers a more effective strategy for managing this pervasive issue.

Fibromyalgia affects millions worldwide, causing widespread body pain, fatigue, sleep disturbances, cognitive issues, and mood changes. Despite its prevalence, treatment options remain limited.

Recent research finds promising results in using ketamine for short-term fibromyalgia relief, and case studies show potential for long-term relief for some patients with chronic pain, too.

The practice of microdosing psychedelics has seen a staggering increase in popularity. A comprehensive study (published June 28, 2024) reveals a 1250% surge in public interest over the past eight years, coinciding with significant legislative changes across the United States.

A recent study underscores the crucial role of physician empathy in improving outcomes for patients with chronic low back pain, highlighting its significance over traditional treatments (including opioids!) and even surgical interventions.